Key Documents

NIH Biosketch available Online

Curriculum Vitae available Online

Marcia L. Stefanick, Ph.D.

Professor (Research), Medicine - Stanford Prevention Research
Professor (Research) (By courtesy), Obstetrics & Gynecology
Member, Cancer Center

Contact Information

Clinical Offices
Academic Offices

Personal Information
Email stefanick@stanford.edu

Administrative Appointments

Professor of Medicine (Research), Stanford University , (2003– present )
Associate Professor of Medicine (Research), Stanford University , (1997– 2003 )

Honors and Awards

Fellow, American Heart Association (2001-present)
Member, Stanford University School of Medicine Committee on Admissions (October 1999-present)
Member, Phi Delta Kappa (International German Honor Society) (19-- to present)
Member, Sigma Xi (Scientific Research Society) (19--to present)
Fellow, American Heart Association Council of Arteriosclerosis, Thrombosis and Vascular Biology (1989-present)
Fellow, American College of Sports Medicine (ASCM) (1984-present)

Professional Education

Ph.D., Stanford University Physiology (1982)
B.A., University of Pennsylvania Biology (1974)

Graduate & Fellowship Program Affiliations

Web Site Links

http://prevention.stanford.edu/

Research Interests

Dr Stefanick is Principal Investigator of Stanford's (1) Women's Health Initiative (WHI) Center which is now following ~3900 women (12% minority), now 60-90 years of age, who have participated in the WHI diet, hormone, or calcium/vitamin trials (focused on heart disease, breast and colorectal cancer and osteoporotic bone fractures) or a study of natural aging since 1995, (2) NCI Women's Healthy Eating and Living (WHEL) trial, which is following 500 of the total 3000 breast cancer survivors enrolled in this NCI trial to determine whether a plant-based diet can prevent breast cancer recurrence; and (3) MrOs, Study of Osteoporotic Fractures in Men (the MrOS study) which is following the health status of nearly 1000 of the 6000 men, aged 65 and over, in the NIAMS MrOS study, with particular interest in osteoporotic fractures and prostate cancer and the role of Sleep on cardiovascular health. Dr. Stefanick is actively involved in Women's Health @ Stanford (based in the Department of Obstetrics and Gynecology) and is currently developing a women's heart health program, HerHeart, for Stanford's Cardiovascular Institute. She is also Leader for the Cancer Prevention and Control Program of Stanford's Comprehensive Cancer Center and Program Director for Stanford's Building Interdisciplinary Research Careers in Women's Health (BIRCWH) mentorship program, funded by the NIH Office of Research on Women's Health.
Dr. Stefanick has been the investigator-elected Chair of the Women’s Health Initiative (WHI) Steering and Executive Committees from 1998 to 2005, at which time she was elected as Chair of the WHI Extension Study Executive Committee, which is overseeing the 5-year continuation of the project nationwide. She participates in a broad range of scientific activities for the NHLBI and American Heart Association. She has been invited to speak at many prominent national and international meetings in the area of chronic disease prevention and health promotion across the lifespan, for men and women, with a special interest in menopause and sex hormones on which she has published extensively, and she lectures on these topics to both undergraduates (including a Fall quarter Human Biology class) and medical school students at Stanford University. She also serves on the Admissions Committee for Stanford's Medical School.

Clinical Trials

Sex Differences in Coronary Pathophysiology Recruiting

Publications

A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer. Kabat GC, Kim M, Chlebowski RT, Khandekar J, Ko MG, McTiernan A, Neuhouser ML, Parker DR, Shikany JM, Stefanick ML, Thomson CA, Rohan TE. Cancer Epidemiol Biomarkers Prev. 2009; 18 (7): 2046-53
Association between sex steroids and cognition in elderly men. Leblanc ES, Wang PY, Janowsky JS, Neiss MB, Fink HA, Yaffe K, Marshall LM, Lapidus JA, Stefanick ML, Orwoll ES. Clin Endocrinol (Oxf). 2009;
Sex hormones and frailty in older men: the osteoporotic fractures in men (MrOS) study. Cawthon PM, Ensrud KE, Laughlin GA, Cauley JA, Dam TT, Barrett-Connor E, Fink HA, Hoffman AR, Lau E, Lane NE, Stefanick ML, Cummings SR, Orwoll ES. J Clin Endocrinol Metab. 2009; 94 (10): 3806-15
Association between sleep architecture and measures of body composition. Rao MN, Blackwell T, Redline S, Stefanick ML, Ancoli-Israel S, Stone KL. Sleep. 2009; 32 (4): 483-90
Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women's Health Initiative clinical trial and observational study. Prentice RL, Pettinger M, Beresford SA, Wactawski-Wende J, Hubbell FA, Stefanick ML, Chlebowski RT. Cancer Epidemiol Biomarkers Prev. 2009; 18 (5): 1531-7
Longitudinal biological exposure to carotenoids is associated with breast cancer-free survival in the Women's Healthy Eating and Living Study. Rock CL, Natarajan L, Pu M, Thomson CA, Flatt SW, Caan BJ, Gold EB, Al-Delaimy WK, Newman VA, Hajek RA, Stefanick ML, Pierce JP. Cancer Epidemiol Biomarkers Prev. 2009; 18 (2): 486-94
Dietary pattern influences breast cancer prognosis in women without hot flashes: the women's healthy eating and living trial. Gold EB, Pierce JP, Natarajan L, Stefanick ML, Laughlin GA, Caan BJ, Flatt SW, Emond JA, Saquib N, Madlensky L, Kealey S, Wasserman L, Thomson CA, Rock CL, Parker BA, Karanja N, Jones V, Hajek RA, Pu M, Mortimer JE. J Clin Oncol. 2009; 27 (3): 352-9
Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy. Resnick SM, Espeland MA, An Y, Maki PM, Coker LH, Jackson R, Stefanick ML, Wallace R, Rapp SR. J Clin Endocrinol Metab. 2009; 94 (11): 4152-61
Dietary change and reduced breast cancer events among women without hot flashes after treatment of early-stage breast cancer: subgroup analysis of the Women's Healthy Eating and Living Study. Pierce JP, Natarajan L, Caan BJ, Flatt SW, Kealey S, Gold EB, Hajek RA, Newman VA, Rock CL, Pu M, Saquib N, Stefanick ML, Thomson CA, Parker B. Am J Clin Nutr. 2009; 89 (5): 1565S-1571S
Biomarker-calibrated energy and protein consumption and increased cancer risk among postmenopausal women. Prentice RL, Shaw PA, Bingham SA, Beresford SA, Caan B, Neuhouser ML, Patterson RE, Stefanick ML, Satterfield S, Thomson CA, Snetselaar L, Thomas A, Tinker LF. Am J Epidemiol. 2009; 169 (8): 977-89
Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial. LaCroix AZ, Kotchen J, Anderson G, Brzyski R, Cauley JA, Cummings SR, Gass M, Johnson KC, Ko M, Larson J, Manson JE, Stefanick ML, Wactawski-Wende J. J Gerontol A Biol Sci Med Sci. 2009; 64 (5): 559-67
Breast cancer after use of estrogen plus progestin in postmenopausal women. Chlebowski RT, Kuller LH, Prentice RL, Stefanick ML, Manson JE, Gass M, Aragaki AK, Ockene JK, Lane DS, Sarto GE, Rajkovic A, Schenken R, Hendrix SL, Ravdin PM, Rohan TE, Yasmeen S, Anderson G. N Engl J Med. 2009; 360 (6): 573-87
Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study. Resnick SM, Espeland MA, Jaramillo SA, Hirsch C, Stefanick ML, Murray AM, Ockene J, Davatzikos C. Neurology. 2009; 72 (2): 135-42
Postmenopausal hormone therapy and subclinical cerebrovascular disease: the WHIMS-MRI Study. Coker LH, Hogan PE, Bryan NR, Kuller LH, Margolis KL, Bettermann K, Wallace RB, Lao Z, Freeman R, Stefanick ML, Shumaker SA. Neurology. 2009; 72 (2): 125-34
Vasomotor symptoms, adoption of a low-fat dietary pattern, and risk of invasive breast cancer: a secondary analysis of the Women's Health Initiative randomized controlled dietary modification trial. Caan BJ, Aragaki A, Thomson CA, Stefanick ML, Chlebowski R, Hubbell FA, Tinker L, Vitolins M, Rajkovic A, Bueche M, Ockene J. J Clin Oncol. 2009; 27 (27): 4500-7
Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. Heiss G, Wallace R, Anderson GL, Aragaki A, Beresford SA, Brzyski R, Chlebowski RT, Gass M, LaCroix A, Manson JE, Prentice RL, Rossouw J, Stefanick ML. JAMA. 2008; 299 (9): 1036-45
Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. Neuhouser ML, Tinker L, Shaw PA, Schoeller D, Bingham SA, Horn LV, Beresford SA, Caan B, Thomson C, Satterfield S, Kuller L, Heiss G, Smit E, Sarto G, Ockene J, Stefanick ML, Assaf A, Runswick S, Prentice RL. Am J Epidemiol. 2008; 167 (10): 1247-59
Estrogen plus progestin therapy and breast cancer in recently postmenopausal women. Prentice RL, Chlebowski RT, Stefanick ML, Manson JE, Pettinger M, Hendrix SL, Hubbell FA, Kooperberg C, Kuller LH, Lane DS, McTiernan A, Jo O'Sullivan M, Rossouw JE, Anderson GL. Am J Epidemiol. 2008; 167 (10): 1207-16
Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study. Prentice RL, Chlebowski RT, Stefanick ML, Manson JE, Langer RD, Pettinger M, Hendrix SL, Hubbell FA, Kooperberg C, Kuller LH, Lane DS, McTiernan A, O'Sullivan MJ, Rossouw JE, Anderson GL. Am J Epidemiol. 2008; 167 (12): 1407-15
Usefulness of baseline lipids and C-reactive protein in women receiving menopausal hormone therapy as predictors of treatment-related coronary events. Bray PF, Larson JC, Lacroix AZ, Manson J, Limacher MC, Rossouw JE, Lasser NL, Lawson WE, Stefanick ML, Langer RD, Margolis KL. Am J Cardiol. 2008; 101 (11): 1599-1605
The association between sleep duration and obesity in older adults. Patel SR, Blackwell T, Redline S, Ancoli-Israel S, Cauley JA, Hillier TA, Lewis CE, Orwoll ES, Stefanick ML, Taylor BC, Yaffe K, Stone KL. Int J Obes (Lond). 2008; 32 (12): 1825-34
Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial. Ritenbaugh C, Stanford JL, Wu L, Shikany JM, Schoen RE, Stefanick ML, Taylor V, Garland C, Frank G, Lane D, Mason E, McNeeley SG, Ascensao J, Chlebowski RT. Cancer Epidemiol Biomarkers Prev. 2008; 17 (10): 2609-18
Sleep duration and risk of ischemic stroke in postmenopausal women. Chen JC, Brunner RL, Ren H, Wassertheil-Smoller S, Larson JC, Levine DW, Allison M, Naughton MJ, Stefanick ML. Stroke. 2008; 39 (12): 3185-92
Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer. Rock CL, Flatt SW, Laughlin GA, Gold EB, Thomson CA, Natarajan L, Jones LA, Caan BJ, Stefanick ML, Hajek RA, Al-Delaimy WK, Stanczyk FZ, Pierce JP. Cancer Epidemiol Biomarkers Prev. 2008; 17 (3): 614-20
Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. Pierce JP, Stefanick ML, Flatt SW, Natarajan L, Sternfeld B, Madlensky L, Al-Delaimy WK, Thomson CA, Kealey S, Hajek R, Parker BA, Newman VA, Caan B, Rock CL. J Clin Oncol. 2007; 25 (17): 2345-51
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML. JAMA. 2007; 297 (13): 1465-77
Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. Pierce JP, Natarajan L, Caan BJ, Parker BA, Greenberg ER, Flatt SW, Rock CL, Kealey S, Al-Delaimy WK, Bardwell WA, Carlson RW, Emond JA, Faerber S, Gold EB, Hajek RA, Hollenbach K, Jones LA, Karanja N, Madlensky L, Marshall J, Newman VA, Ritenbaugh C, Thomson CA, Wasserman L, Stefanick ML. JAMA. 2007; 298 (3): 289-98
Telephone counseling helps maintain long-term adherence to a high-vegetable dietary pattern. Pierce JP, Newman VA, Natarajan L, Flatt SW, Al-Delaimy WK, Caan BJ, Emond JA, Faerber S, Gold EB, Hajek RA, Hollenbach K, Jones LA, Karanja N, Kealey S, Madlensky L, Marshall J, Ritenbaugh C, Rock CL, Stefanick ML, Thomson C, Wasserman L, Parker BA. J Nutr. 2007; 137 (10): 2291-6
Factors associated with 5-year risk of hip fracture in postmenopausal women. Robbins J, Aragaki AK, Kooperberg C, Watts N, Wactawski-Wende J, Jackson RD, LeBoff MS, Lewis CE, Chen Z, Stefanick ML, Cauley J. JAMA. 2007; 298 (20): 2389-98
Estrogen therapy and coronary-artery calcification. Manson JE, Allison MA, Rossouw JE, Carr JJ, Langer RD, Hsia J, Kuller LH, Cochrane BB, Hunt JR, Ludlam SE, Pettinger MB, Gass M, Margolis KL, Nathan L, Ockene JK, Prentice RL, Robbins J, Stefanick ML. N Engl J Med. 2007; 356 (25): 2591-602
Dietary factors and vasomotor symptoms in breast cancer survivors: the WHEL Study. Gold EB, Flatt SW, Pierce JP, Bardwell WA, Hajek RA, Newman VA, Rock CL, Stefanick ML. Menopause. 2006 May-Jun; 13 (3): 423-33
Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. Stefanick ML, Anderson GL, Margolis KL, Hendrix SL, Rodabough RJ, Paskett ED, Lane DS, Hubbell FA, Assaf AR, Sarto GE, Schenken RS, Yasmeen S, Lessin L, Chlebowski RT. JAMA. 2006; 295 (14): 1647-57
Risk-benefit profiles of raloxifene for women. Stefanick ML, N Engl J Med. 2006; 355 (2): 190-2
Mortality and cardiac and vascular outcomes in extremely obese women. McTigue K, Larson JC, Valoski A, Burke G, Kotchen J, Lewis CE, Stefanick ML, Van Horn L, Kuller L. JAMA. 2006; 296 (1): 79-86
Endogenous sex steroids, weight change and rates of hip bone loss in older men: the MrOS study. Ensrud KE, Lewis CE, Lambert LC, Taylor BC, Fink HA, Barrett-Connor E, Cauley JA, Stefanick ML, Orwoll E. Osteoporos Int. 2006; 17 (9): 1329-36
Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer. Caan BJ, Emond JA, Natarajan L, Castillo A, Gunderson EP, Habel L, Jones L, Newman VA, Rock CL, Slattery ML, Stefanick ML, Sternfeld B, Thomson CA, Pierce JP. Breast Cancer Res Treat. 2006; 99 (1): 47-57
Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease. Prentice RL, Langer RD, Stefanick ML, Howard BV, Pettinger M, Anderson GL, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J. Am J Epidemiol. 2006; 163 (7): 589-99
Calcium plus vitamin D supplementation and the risk of colorectal cancer. Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ, Margolis KL, Ockene JK, Phillips L, Pottern L, Prentice RL, Robbins J, Rohan TE, Sarto GE, Sharma S, Stefanick ML, Van Horn L, Wallace RB, Whitlock E, Bassford T, Beresford SA, Black HR, Bonds DE, Brzyski RG, Caan B, Chlebowski RT, Cochrane B, Garland C, Gass M, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Jackson RD, Johnson KC, Judd H, Kooperberg CL, Kuller LH, LaCroix AZ, Lane DS, Langer RD, Lasser NL, Lewis CE, Limacher MC, Manson JE. N Engl J Med. 2006; 354 (7): 684-96
Calcium plus vitamin D supplementation and the risk of fractures. Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SA, Black HR, Blanchette P, Bonds DE, Brunner RL, Brzyski RG, Caan B, Cauley JA, Chlebowski RT, Cummings SR, Granek I, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Johnson KC, Judd H, Kotchen JM, Kuller LH, Langer RD, Lasser NL, Limacher MC, Ludlam S, Manson JE, Margolis KL, McGowan J, Ockene JK, O'Sullivan MJ, Phillips L, Prentice RL, Sarto GE, Stefanick ML, Van Horn L, Wactawski-Wende J, Whitlock E, Anderson GL, Assaf AR, Barad D. N Engl J Med. 2006; 354 (7): 669-83
Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML, Wassertheil-Smoller S, Kuller LH, LaCroix AZ, Langer RD, Lasser NL, Lewis CE, Limacher MC, Margolis KL, Mysiw WJ, Ockene JK, Parker LM, Perri MG, Phillips L, Prentice RL, Robbins J, Rossouw JE, Sarto GE, Schatz IJ, Snetselaar LG, Stevens VJ, Tinker LF, Trevisan M, Vitolins MZ, Anderson GL, Assaf AR, Bassford T, Beresford SA, Black HR, Brunner RL, Brzyski RG, Caan B, Chlebowski RT, Gass M, Granek I, Greenland P, Hays J, Heber D, Heiss G, Hendrix SL, Hubbell FA, Johnson KC, Kotchen JM. JAMA. 2006; 295 (6): 655-66
Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. Beresford SA, Johnson KC, Ritenbaugh C, Lasser NL, Snetselaar LG, Black HR, Anderson GL, Assaf AR, Bassford T, Bowen D, Brunner RL, Brzyski RG, Caan B, Chlebowski RT, Gass M, Harrigan RC, Hays J, Heber D, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Jackson RD, Kotchen JM, Kuller LH, LaCroix AZ, Lane DS, Langer RD, Lewis CE, Manson JE, Margolis KL, Mossavar-Rahmani Y, Ockene JK, Parker LM, Perri MG, Phillips L, Prentice RL, Robbins J, Rossouw JE, Sarto GE, Stefanick ML, Van Horn L, Vitolins MZ, Wactawski-Wende J, Wallace RB, Whitlock E. JAMA. 2006; 295 (6): 643-54
Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. Prentice RL, Caan B, Chlebowski RT, Patterson R, Kuller LH, Ockene JK, Margolis KL, Limacher MC, Manson JE, Parker LM, Paskett E, Phillips L, Robbins J, Rossouw JE, Sarto GE, Shikany JM, Stefanick ML, Thomson CA, Van Horn L, Vitolins MZ, Wactawski-Wende J, Wallace RB, Wassertheil-Smoller S, Whitlock E, Yano K, Adams-Campbell L, Anderson GL, Assaf AR, Beresford SA, Black HR, Brunner RL, Brzyski RG, Ford L, Gass M, Hays J, Heber D, Heiss G, Hendrix SL, Hsia J, Hubbell FA, Jackson RD, Johnson KC, Kotchen JM, LaCroix AZ, Lane DS, Langer RD, Lasser NL, Henderson MM. JAMA. 2006; 295 (6): 629-42
Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. Howard BV, Manson JE, Stefanick ML, Beresford SA, Frank G, Jones B, Rodabough RJ, Snetselaar L, Thomson C, Tinker L, Vitolins M, Prentice R. JAMA. 2006; 295 (1): 39-49
Obesity, hormone therapy, estrogen metabolism and risk of postmenopausal breast cancer. Modugno F, Kip KE, Cochrane B, Kuller L, Klug TL, Rohan TE, Chlebowski RT, Lasser N, Stefanick ML. Int J Cancer. 2006; 118 (5): 1292-301
Postmenopausal hormone therapy and body composition--a substudy of the estrogen plus progestin trial of the Women's Health Initiative. Chen Z, Bassford T, Green SB, Cauley JA, Jackson RD, LaCroix AZ, Leboff M, Stefanick ML, Margolis KL. Am J Clin Nutr. 2005; 82 (3): 651-6
Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men. Orwoll E, Blank JB, Barrett-Connor E, Cauley J, Cummings S, Ensrud K, Lewis C, Cawthon PM, Marcus R, Marshall LM, McGowan J, Phipps K, Sherman S, Stefanick ML, Stone K. Contemp Clin Trials. 2005; 26 (5): 569-85
Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial. Prentice RL, Langer R, Stefanick ML, Howard BV, Pettinger M, Anderson G, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J. Am J Epidemiol. 2005; 162 (5): 404-14
Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women's Health Initiative Observational Study. Howard BV, Kuller L, Langer R, Manson JE, Allen C, Assaf A, Cochrane BB, Larson JC, Lasser N, Rainford M, Van Horn L, Stefanick ML, Trevisan M. Circulation. 2005; 111 (12): 1462-70
The rise and fall of menopausal hormone therapy. Barrett-Connor E, Grady D, Stefanick ML. Annu Rev Public Health. 2005; 26 115-40
Association between reported alcohol intake and cognition: results from the Women's Health Initiative Memory Study. Espeland MA, Gu L, Masaki KH, Langer RD, Coker LH, Stefanick ML, Ockene J, Rapp SR. Am J Epidemiol. 2005; 161 (3): 228-38
Voluntary weight reduction in older men increases hip bone loss: the osteoporotic fractures in men study. Ensrud KE, Fullman RL, Barrett-Connor E, Cauley JA, Stefanick ML, Fink HA, Lewis CE, Orwoll E. J Clin Endocrinol Metab. 2005; 90 (4): 1998-2004
Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration. Stefanick ML, Am J Med. 2005; 118 Suppl 12B 64-73
Insulin, physical activity, and caloric intake in postmenopausal women: breast cancer implications. Chlebowski RT, Pettinger M, Stefanick ML, Howard BV, Mossavar-Rahmani Y, McTiernan A. J Clin Oncol. 2004; 22 (22): 4507-13
On the importance of using multiple methods of dietary assessment. Natarajan L, Rock CL, Major JM, Thomson CA, Caan BJ, Flatt SW, Chilton JA, Hollenbach KA, Newman VA, Faerber S, Ritenbaugh CK, Gold E, Stefanick ML, Jones LA, Marshall JR, Pierce JP. Epidemiology. 2004; 15 (6): 738-45
Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH. JAMA. 2004; 291 (24): 2947-58
Effects of a high-fiber, low-fat diet intervention on serum concentrations of reproductive steroid hormones in women with a history of breast cancer. Rock CL, Flatt SW, Thomson CA, Stefanick ML, Newman VA, Jones LA, Natarajan L, Ritenbaugh C, Hollenbach KA, Pierce JP, Chang RJ. J Clin Oncol. 2004; 22 (12): 2379-87
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S. JAMA. 2004; 291 (14): 1701-12
Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002 : Section 4: lessons from hormone replacement trials. Waters DD, Gordon D, Rossouw JE, Cannon RO, Collins P, Herrington DM, Hsia J, Langer R, Mosca L, Ouyang P, Sopko G, Stefanick ML. Circulation. 2004; 109 (6): e53-5
Telephone counseling intervention increases intakes of micronutrient- and phytochemical-rich vegetables, fruit and fiber in breast cancer survivors. Pierce JP, Newman VA, Flatt SW, Faerber S, Rock CL, Natarajan L, Caan BJ, Gold EB, Hollenbach KA, Wasserman L, Jones L, Ritenbaugh C, Stefanick ML, Thomson CA, Kealey S. J Nutr. 2004; 134 (2): 452-8
National use of postmenopausal hormone therapy: annual trends and response to recent evidence. Hersh AL, Stefanick ML, Stafford RS. JAMA. 2004; 291 (1): 47-53
Plasma triacylglycerol and HDL cholesterol concentrations confirm self-reported changes in carbohydrate and fat intakes in women in a diet intervention trial. Rock CL, Flatt SW, Thomson CA, Stefanick ML, Newman VA, Jones L, Natarajan L, Pierce JP, Chang RJ, Witztum JL. J Nutr. 2004; 134 (2): 342-7
The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants. Stefanick ML, Cochrane BB, Hsia J, Barad DH, Liu JH, Johnson SR. Ann Epidemiol. 2003; 13 (9 Suppl): S78-86
Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D. JAMA. 2003; 289 (20): 2663-72
Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, Khandekar J, Petrovitch H, McTiernan A. JAMA. 2003; 289 (24): 3243-53
Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J, Watts NB. JAMA. 2003; 290 (13): 1729-38
Stage of motivational readiness: predictive ability for exercise behavior. Young DR, King AC, Sheehan M, Stefanick ML. Am J Health Behav. 2002 Sep-Oct; 26 (5): 331-41
Effects of food availability on serum insulin and lipid concentrations in free-ranging baboons. Kemnitz JW, Sapolsky RM, Altmann J, Muruthi P, Mott GE, Stefanick ML. Am J Primatol. 2002; 57 (1): 13-9
Walking compared with vigorous exercise for the prevention of cardiovascular events in women. Manson JE, Greenland P, LaCroix AZ, Stefanick ML, Mouton CP, Oberman A, Perri MG, Sheps DS, Pettinger MB, Siscovick DS. N Engl J Med. 2002; 347 (10): 716-25
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J. JAMA. 2002; 288 (3): 321-33
Compliance with National Cholesterol Education Program dietary and lifestyle guidelines among older women with self-reported hypercholesterolemia. The Women's Health Initiative. Hsia J, Rodabough R, Rosal MC, Cochrane B, Howard BV, Snetselaar L, Frishman WH, Stefanick ML. Am J Med. 2002; 113 (5): 384-92
Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Morimoto LM, White E, Chen Z, Chlebowski RT, Hays J, Kuller L, Lopez AM, Manson J, Margolis KL, Muti PC, Stefanick ML, McTiernan A. Cancer Causes Control. 2002; 13 (8): 741-51
Menopausal symptoms in older women and the effects of treatment with hormone therapy. Barnabei VM, Grady D, Stovall DW, Cauley JA, Lin F, Stuenkel CA, Stefanick ML, Pickar JH. Obstet Gynecol. 2002; 100 (6): 1209-18
A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) Study. Pierce JP, Faerber S, Wright FA, Rock CL, Newman V, Flatt SW, Kealey S, Jones VE, Caan BJ, Gold EB, Haan M, Hollenbach KA, Jones L, Marshall JR, Ritenbaugh C, Stefanick ML, Thomson C, Wasserman L, Natarajan L, Thomas RG, Gilpin EA. Control Clin Trials. 2002; 23 (6): 728-56
Reduction in fat intake is not associated with weight loss in most women after breast cancer diagnosis: evidence from a randomized controlled trial. Rock CL, Thomson C, Caan BJ, Flatt SW, Newman V, Ritenbaugh C, Marshall JR, Hollenbach KA, Stefanick ML, Pierce JP. Cancer. 2001; 91 (1): 25-34
Men gain additional psychological benefits by adding exercise to a weight-loss program. Kiernan M, King AC, Stefanick ML, Killen JD. Obes Res. 2001; 9 (12): 770-7
Correlates of high HDL cholesterol among women with coronary heart disease. Bittner V, Simon JA, Fong J, Blumenthal RS, Newby K, Stefanick ML. Am Heart J. 2000; 139 (2 Pt 1): 288-96
Knowledge and perceived risk of major diseases in middle-aged and older women. Wilcox S, Stefanick ML. Health Psychol. 1999; 18 (4): 346-53
Physical activity for preventing and treating obesity-related dyslipoproteinemias. Stefanick ML, Med Sci Sports Exerc. 1999; 31 (11 Suppl): S609-18
Factors associated with weight gain in women after diagnosis of breast cancer. Women's Healthy Eating and Living Study Group. Rock CL, Flatt SW, Newman V, Caan BJ, Haan MN, Stefanick ML, Faerber S, Pierce JP. J Am Diet Assoc. 1999; 99 (10): 1212-21
Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Cushman M, Legault C, Barrett-Connor E, Stefanick ML, Kessler C, Judd HL, Sakkinen PA, Tracy RP. Circulation. 1999; 100 (7): 717-22
Effect of hormone replacement therapy on the validity of the Friedewald equation in postmenopausal women: the postmenopausal estrogen/progestins interventions (PEPI) trial. Legault C, Stefanick ML, Miller VT, Marcovina SM, Schrott HG. J Clin Epidemiol. 1999; 52 (12): 1187-95
Characteristics of successful and unsuccessful dieters: an application of signal detection methodology. Kiernan M, King AC, Kraemer HC, Stefanick ML, Killen JD. Ann Behav Med. 1998; 20 (1): 1-6
Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol. Stefanick ML, Mackey S, Sheehan M, Ellsworth N, Haskell WL, Wood PD. N Engl J Med. 1998; 339 (1): 12-20
Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators. Espeland MA, Stefanick ML, Kritz-Silverstein D, Fineberg SE, Waclawiw MA, James MK, Greendale GA. J Clin Endocrinol Metab. 1997; 82 (5): 1549-56
Distribution and correlates of plasma fibrinogen in middle-aged women. Initial findings of the Postmenopausal Estrogen/Progestin Interventions (PEPI) study. Stefanick ML, Legault C, Tracy RP, Howard G, Kessler CM, Lucas DL, Bush TL. Arterioscler Thromb Vasc Biol. 1995; 15 (12): 2085-93
Physical and laboratory measurements in the PEPI Trial Postmenopausal Estrogen/Progestin Interventions. Wood PD, Kessler G, Lippel K, Stefanick ML, Wasilauskas CH, Wells HB. Control Clin Trials. 1995; 16 (4 Suppl): 36S-53S
Long-term effects of varying intensities and formats of physical activity on participation rates, fitness, and lipoproteins in men and women aged 50 to 65 years. King AC, Haskell WL, Young DR, Oka RK, Stefanick ML. Circulation. 1995; 91 (10): 2596-604
Rationale, design, and conduct of the PEPI Trial. Postmenopausal Estrogen/Progestin Interventions. Espeland MA, Bush TL, Mebane-Sims I, Stefanick ML, Johnson S, Sherwin R, Waclawiw M. Control Clin Trials. 1995; 16 (4 Suppl): 3S-19S
Effects of low-fat diet, calorie restriction, and running on lipoprotein subfraction concentrations in moderately overweight men. Williams PT, Krauss RM, Stefanick ML, Vranizan KM, Wood PD. Metabolism. 1994; 43 (5): 655-63
The effects of weight loss by exercise or by dieting on plasma high-density lipoprotein (HDL) levels in men with low, intermediate, and normal-to-high HDL at baseline. Williams PT, Stefanick ML, Vranizan KM, Wood PD. Metabolism. 1994; 43 (7): 917-24
Exercise and weight control. Stefanick ML, Exerc Sport Sci Rev. 1993; 21 363-96
Associations of lipoproteins and apolipoproteins with gradient gel electrophoresis estimates of high density lipoprotein subfractions in men and women. Williams PT, Krauss RM, Vranizan KM, Stefanick ML, Wood PD, Lindgren FT. Arterioscler Thromb. 1992; 12 (3): 332-40
Hormones and sexual behavior in relationship to aging in male rats. Smith ER, Stefanick ML, Clark JT, Davidson JM. Horm Behav. 1992; 26 (1): 110-35
Contributions of regional adipose tissue depots to plasma lipoprotein concentrations in overweight men and women: possible protective effects of thigh fat. Terry RB, Stefanick ML, Haskell WL, Wood PD. Metabolism. 1991; 40 (7): 733-40
The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. Wood PD, Stefanick ML, Williams PT, Haskell WL. N Engl J Med. 1991; 325 (7): 461-6
Regional adiposity patterns in relation to lipids, lipoprotein cholesterol, and lipoprotein subfraction mass in men. Terry RB, Wood PD, Haskell WL, Stefanick ML, Krauss RM. J Clin Endocrinol Metab. 1989; 68 (1): 191-9
Insulin resistance and hypertriglyceridemia in nondiabetic relatives of patients with noninsulin-dependent diabetes mellitus. Laws A, Stefanick ML, Reaven GM. J Clin Endocrinol Metab. 1989; 69 (2): 343-7
Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. Wood PD, Stefanick ML, Dreon DM, Frey-Hewitt B, Garay SC, Williams PT, Superko HR, Fortmann SP, Albers JJ, Vranizan KM. N Engl J Med. 1988; 319 (18): 1173-9
Genital responses in noncopulators and rats with lesions in the medical preoptic area or midthoracic spinal cord. Stefanick ML, Davidson JM. Physiol Behav. 1987; 41 (5): 439-44
Relationships of plasma estradiol, testosterone, and sex hormone-binding globulin with lipoproteins, apolipoproteins, and high density lipoprotein subfractions in men. Stefanick ML, Williams PT, Krauss RM, Terry RB, Vranizan KM, Wood PD. J Clin Endocrinol Metab. 1987; 64 (4): 723-9
Reproductive physiology and behavior in the male rat following acute and chronic peripheral adrenergic depletion by guanethidine. Stefanick ML, Smith ER, Szumowski DA, Davidson JM. Pharmacol Biochem Behav. 1985; 23 (1): 55-63
The circadian patterns of spontaneous seminal emission, sexual activity and penile reflexes in the rat. Stefanick ML, Physiol Behav. 1983; 31 (6): 737-43
Further studies on alterations in male rat copulatory behavior induced by the dopamine-receptor agonist RDS-127. Clark JT, Stefanick ML, Smith ER, Davidson JM. Pharmacol Biochem Behav. 1983; 19 (5): 781-6
Penile reflexes in intact rats following anesthetization of the penis and ejaculation. Stefanick ML, Smith ER, Davidson JM. Physiol Behav. 1983; 31 (1): 63-5
Sexual experience and plasma testosterone levels in male veterans after spinal cord injury. Phelps G, Brown M, Chen J, Dunn M, Lloyd E, Stefanick ML, Davidson JM, Perkash I. Arch Phys Med Rehabil. 1983; 64 (2): 47-52
Effects of a potent dopamine receptor agonist, RDS-127, on penile reflexes and seminal emission in intact and spinally transected rats. Stefanick ML, Smith ER, Clark JT, Davidson JM. Physiol Behav. 1982; 29 (6): 973-8
Role of androgen in sexual reflexes of the male rat. Davidson JM, Stefanick ML, Sachs BD, Smith ER. Physiol Behav. 1978; 21 (2): 141-6